Balance Sheet for INM - findataslice
 InMed Pharmaceuticals Inc.
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021
Total Assets15,580,040$9,279,834$8,502,292$10,465,106$11,822,782$13,358,716$15,255,464$10,917,339$14,106,340$14,730,101$16,919,696$14,584,330$12,787,580$15,485,797$19,383,720$17,327,264$9,781,216$12,344,999$11,747,422$6,603,674$7,802,597$
Total Current Assets12,867,279$6,410,063$5,470,120$7,279,892$8,689,585$10,064,002$11,810,070$8,295,208$11,331,727$11,842,545$14,017,715$11,542,909$9,597,776$8,746,886$12,505,026$15,976,323$8,378,269$10,896,704$10,249,388$5,116,527$6,312,457$
Cash and Cash Equivalents11,075,871$4,679,826$3,419,422$5,583,039$6,571,610$7,600,598$9,534,922$6,738,304$8,912,517$9,604,057$11,452,578$9,350,427$6,176,866$5,898,313$11,279,964$15,343,905$7,363,126$9,454,113$10,020,853$4,497,296$5,805,809$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets2,712,761$2,869,771$3,032,172$3,185,214$3,133,197$3,294,714$3,445,394$2,622,131$2,774,613$2,887,556$2,901,981$3,041,421$3,189,804$6,738,911$6,878,694$1,350,941$1,402,947$1,448,295$1,498,034$1,487,147$1,490,140$
Goodwill2,023,039$2,023,039$
Other Intangible Assets1,620,562$1,661,109$1,701,211$1,742,205$1,783,198$1,823,745$1,864,292$1,905,286$1,946,279$1,986,826$2,026,929$2,067,922$2,108,915$2,355,401$2,400,831$1,037,382$1,061,697$1,085,748$1,109,535$1,088,630$1,086,655$
Physical Assets992,199$1,108,662$1,230,961$1,343,009$1,249,999$1,370,969$1,481,102$615,055$723,426$753,241$703,922$802,369$904,252$1,002,846$1,096,649$304,934$326,595$347,892$373,844$384,529$403,485$
Other Noncurrent Assets100,000$100,000$100,000$100,000$100,000$100,000$100,000$101,790$104,908$147,489$171,130$171,130$176,637$108,625$109,175$8,625$14,655$14,655$14,655$13,988$
Assets Held for Sale in Long Term
Total Liabilities2,145,545$2,258,309$2,320,192$2,069,662$2,616,673$2,254,066$2,483,253$1,339,249$2,016,613$2,342,463$2,584,645$3,576,390$3,709,039$4,599,064$5,216,407$2,105,592$2,404,649$1,930,529$4,156,609$2,109,628$1,924,279$
Total Current Liabilities1,839,790$1,838,962$1,790,944$1,435,879$1,971,808$1,528,830$1,680,469$1,339,249$2,000,619$2,269,669$2,400,743$3,282,053$3,319,541$4,105,502$4,617,765$1,927,001$2,215,361$1,714,295$2,153,637$1,874,030$1,676,268$
Accounts Payable2,000$41,004$
Short Term Debt
Short Term Capital Lease Obligations435,507$429,247$419,711$424,260$317,797$345,545$364,190$292,998$375,713$423,574$414,307$404,163$404,276$399,904$391,805$82,232$80,483$78,818$76,312$71,402$68,965$
Other Current Liabilities
Total Noncurrent Liabilities305,755$419,347$529,248$633,783$644,865$725,236$802,784$0$15,994$72,794$183,902$294,337$389,498$493,562$598,642$178,591$189,288$216,234$2,002,972$235,598$248,011$
Long Term Debt
Long Term Capital Lease Obligations305,755$419,347$529,248$633,783$644,865$725,236$802,784$15,994$72,794$183,902$294,337$389,498$493,562$598,642$178,591$189,288$216,234$238,992$235,598$248,011$
Other Noncurrent Liabilities
Total Equity13,434,495$7,021,525$6,182,100$8,395,444$9,206,109$11,104,650$12,772,211$(9,578,090$)12,089,727$12,387,638$14,335,051$11,007,940$9,078,541$10,886,733$14,167,313$15,221,672$7,376,567$10,414,470$7,590,813$4,494,046$5,878,318$7,072,509$9,610,208$11,469,595$
Equity to Minority
Equity to Common Shareholders13,434,495$7,021,525$6,182,100$8,395,444$9,206,109$11,104,650$12,772,211$(9,578,090$)12,089,727$12,387,638$14,335,051$11,007,940$9,078,541$10,886,733$14,167,313$15,221,672$7,376,567$10,414,470$7,590,813$4,494,046$5,878,318$7,072,509$9,610,208$11,469,595$
Additional Paid-In Capital38,122,231$35,741,115$35,700,635$38,407,932$35,170,766$31,684,098$26,515,397$27,049,042$29,230,464$21,513,051$21,292,201$17,946,374$17,849,740$17,764,333$
Retained Earnings(117,237,892$)(115,449,581$)(113,328,651$)(110,753,627$)(109,075,759$)(107,138,088$)(105,415,222$)(103,937,037$)(101,400,209$)(101,061,818$)(99,063,874$)(96,962,787$)(93,452,587$)(85,582,564$)(82,106,899$)(77,824,085$)(74,852,470$)(71,593,717$)(68,492,242$)(66,248,460$)(64,649,381$)
Treasury Stock
Capital Lease Obligations741,262$848,594$948,959$1,058,043$962,662$1,070,781$1,166,974$292,998$391,707$825,427$825,427$825,427$385,057$385,057$385,057$385,057$385,057$